Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D. Gillmore, Jonathan C. Fox, Laura Obici et al.|New England Journal of Medicine|2024Cited by 453
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, Mathew S. Maurer, John L. Berk et al.|New England Journal of Medicine|2024Cited by 356
Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind TrialKristoffer Berg‐Hansen, Henrik Wiggers, Nigopan Gopalasingam et al.|Circulation|2024Cited by 71
A Randomised, Double-Blind, Placebo-Controlled Trial of Metformin on Myocardial Efficiency in Insulin-Resistant Chronic Heart Failure Patients without DiabetesAnders Hostrup Larsen, Henrik Wiggers, Niels Jessen et al.|European Journal of Heart Failure|2019Cited by 66
Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection FractionNigopan Gopalasingam, Henrik Wiggers, Kristoffer Berg‐Hansen et al.|Circulation|2024Cited by 54